| May 15, 2013
| 3:57 PM
LOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments.
An approach to oncology that has been in place...
| May 23, 2011
| 3:53 PM
Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co.
Incivek, a pill...
| Aug 22, 2011
| 11:50 AM
The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost.
The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first...
| Jul 15, 2012
| 8:05 AM
CHICAGO (Reuters) - At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years.
But a string of failed attempts - punctuated by a...
| Feb 1, 2012
On Monday, the U.S. Food & Drug Administration approved a new drug to treat advanced basal cell carcinoma, the most common form of skin cancer. This is good news for the approximately 2.8 million Americans who will be diagnosed with a basal-cell...
| Nov 7, 2009
Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition.
FOR THE RECORD:
Accutane's side effects: An article in Saturday's Section A about the possibility of...